Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWY | ISIN: US92859E2072 | Ticker-Symbol:
NASDAQ
05.06.25 | 20:38
2,260 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VIVOS THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur VIVOS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.05.Vivos Therapeutics, Inc. - 8-K, Current Report1
16.05.Vivos Therapeutics GAAP EPS of -$0.45 misses by $0.10, revenue of $3.02M misses by $1.18M2
16.05.Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 20251
15.05.Vivos Therapeutics, Inc. - 8-K, Current Report2
15.05.Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update117Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its...
► Artikel lesen
17.04.Vivos Therapeutics, Inc. - 8-K, Current Report3
16.04.Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada1
VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln
16.04.Vivos Therapeutics, Inc: Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada92By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to...
► Artikel lesen
31.03.Vivos Therapeutics, Inc. - 8-K, Current Report1
31.03.Vivos Therapeutics GAAP EPS of -$2.22 misses by $0.20, revenue of $15.03M misses by $0.17M5
31.03.Vivos Therapeutics, Inc: Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update75Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo....
► Artikel lesen
31.03.Vivos Therapeutics, Inc. - 10-K, Annual Report3
28.03.Earnings Outlook For Vivos Therapeutics2
18.02.Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.1
14.02.Vivos Therapeutics, Inc. - 8-K, Current Report-
11.02.Vivos Therapeutics announces up to $50M mixed shelf offering1
29.01.Vivos Therapeutics, Inc. - S-1/A, General form for registration of securities-
22.01.Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders1
22.01.Vivos Therapeutics, Inc. - S-1, General form for registration of securities-
23.12.24Vivos Therapeutics, Inc. - 8-K, Current Report-
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1